We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Richer fields elsewhere

7 January 2009 By Robert Cyran

The ten biggest drug makers spent more than $50bn on research in 2008. For the same amount, they could own the entire US biotech industry save the five biggest companies. It might be a better use of their cash.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)